FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204205013> ?p ?o ?g. }

• W3204205013 endingPage "121.e5" @default.
• W3204205013 startingPage "109" @default.
• W3204205013 abstract "Background & AimsAlthough gastroparesis carries a considerable health care and patient burden, associated epidemiological data are limited. To provide new real-world evidence for gastroparesis, we estimated disease prevalence, and investigated patient demographics and disease etiology in a large US claims database.MethodsThis retrospective, cross-sectional analysis used de-identified, longitudinal patient-level enrollment and billing data for adults from the Optum Clinformatics Data Mart database, a large US national administrative health insurance claims database. Prevalence was age-, sex-, and geographical region–standardized using the 2018 US census. Descriptive analyses of demographic and clinical variables and underlying disease etiologies were performed.ResultsThe overall standardized prevalence of gastroparesis was 267.7 (95% confidence interval [CI] 264.8–270.7) per 100,000 US adults, whereas prevalence of “definite” gastroparesis (individuals diagnosed within 3 months of gastric emptying scintigraphy testing with persistent symptoms for more than 3 months) was 21.5 (95% CI 20.6–22.4) per 100,000 persons. Patients with gastroparesis had an overall Charlson Comorbidity Index score of 4.2, indicating substantial comorbidity burden. The most frequently documented comorbidities were chronic pulmonary disease (46.4%), diabetes with chronic complication (37.3%), and peripheral vascular disease (30.4%). Patients most commonly had a diabetic etiology (57.4%; type 1, 5.7% and type 2, 51.7%), followed by postsurgical (15.0%), drug-induced (11.8%), and idiopathic (11.3%) etiologies.ConclusionsNew evidence is provided regarding the prevalence, patient demographics, and etiology of gastroparesis in the US general population. Wider availability of reliable objective gastric emptying measures and further education of medical professionals in recognizing and diagnosing gastroparesis would benefit future studies and improve understanding of disease epidemiology. Although gastroparesis carries a considerable health care and patient burden, associated epidemiological data are limited. To provide new real-world evidence for gastroparesis, we estimated disease prevalence, and investigated patient demographics and disease etiology in a large US claims database. This retrospective, cross-sectional analysis used de-identified, longitudinal patient-level enrollment and billing data for adults from the Optum Clinformatics Data Mart database, a large US national administrative health insurance claims database. Prevalence was age-, sex-, and geographical region–standardized using the 2018 US census. Descriptive analyses of demographic and clinical variables and underlying disease etiologies were performed. The overall standardized prevalence of gastroparesis was 267.7 (95% confidence interval [CI] 264.8–270.7) per 100,000 US adults, whereas prevalence of “definite” gastroparesis (individuals diagnosed within 3 months of gastric emptying scintigraphy testing with persistent symptoms for more than 3 months) was 21.5 (95% CI 20.6–22.4) per 100,000 persons. Patients with gastroparesis had an overall Charlson Comorbidity Index score of 4.2, indicating substantial comorbidity burden. The most frequently documented comorbidities were chronic pulmonary disease (46.4%), diabetes with chronic complication (37.3%), and peripheral vascular disease (30.4%). Patients most commonly had a diabetic etiology (57.4%; type 1, 5.7% and type 2, 51.7%), followed by postsurgical (15.0%), drug-induced (11.8%), and idiopathic (11.3%) etiologies. New evidence is provided regarding the prevalence, patient demographics, and etiology of gastroparesis in the US general population. Wider availability of reliable objective gastric emptying measures and further education of medical professionals in recognizing and diagnosing gastroparesis would benefit future studies and improve understanding of disease epidemiology." @default.
• W3204205013 created "2021-10-11" @default.
• W3204205013 creator A5001729912 @default.
• W3204205013 creator A5021261854 @default.
• W3204205013 creator A5036084171 @default.
• W3204205013 creator A5039869351 @default.
• W3204205013 creator A5048549352 @default.
• W3204205013 creator A5059564658 @default.
• W3204205013 date "2022-01-01" @default.
• W3204205013 modified "2023-10-16" @default.
• W3204205013 title "Epidemiology, Etiology, and Treatment of Gastroparesis: Real-World Evidence From a Large US National Claims Database" @default.
• W3204205013 cites W1968058596 @default.
• W3204205013 cites W1996347667 @default.
• W3204205013 cites W1997587937 @default.
• W3204205013 cites W2031077650 @default.
• W3204205013 cites W2054526512 @default.
• W3204205013 cites W2061326496 @default.
• W3204205013 cites W2072814881 @default.
• W3204205013 cites W2122114281 @default.
• W3204205013 cites W2137389079 @default.
• W3204205013 cites W2150285448 @default.
• W3204205013 cites W2163545331 @default.
• W3204205013 cites W2317904340 @default.
• W3204205013 cites W2509144849 @default.
• W3204205013 cites W2532691906 @default.
• W3204205013 cites W2577355142 @default.
• W3204205013 cites W2607035474 @default.
• W3204205013 cites W2702592772 @default.
• W3204205013 cites W2783817290 @default.
• W3204205013 cites W2791381101 @default.
• W3204205013 cites W2807046356 @default.
• W3204205013 cites W2896621550 @default.
• W3204205013 cites W2902142887 @default.
• W3204205013 cites W2945512725 @default.
• W3204205013 cites W2946839143 @default.
• W3204205013 cites W2979887792 @default.
• W3204205013 cites W2989185923 @default.
• W3204205013 cites W2996959176 @default.
• W3204205013 cites W3031689171 @default.
• W3204205013 cites W3128851695 @default.
• W3204205013 cites W4211124962 @default.
• W3204205013 cites W4248022597 @default.
• W3204205013 doi "https://doi.org/10.1053/j.gastro.2021.09.064" @default.
• W3204205013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34624355" @default.
• W3204205013 hasPublicationYear "2022" @default.
• W3204205013 type Work @default.
• W3204205013 sameAs 3204205013 @default.
• W3204205013 citedByCount "35" @default.
• W3204205013 countsByYear W32042050132022 @default.
• W3204205013 countsByYear W32042050132023 @default.
• W3204205013 crossrefType "journal-article" @default.
• W3204205013 hasAuthorship W3204205013A5001729912 @default.
• W3204205013 hasAuthorship W3204205013A5021261854 @default.
• W3204205013 hasAuthorship W3204205013A5036084171 @default.
• W3204205013 hasAuthorship W3204205013A5039869351 @default.
• W3204205013 hasAuthorship W3204205013A5048549352 @default.
• W3204205013 hasAuthorship W3204205013A5059564658 @default.
• W3204205013 hasBestOaLocation W32042050131 @default.
• W3204205013 hasConcept C107130276 @default.
• W3204205013 hasConcept C126322002 @default.
• W3204205013 hasConcept C134018914 @default.
• W3204205013 hasConcept C137627325 @default.
• W3204205013 hasConcept C187212893 @default.
• W3204205013 hasConcept C2778769438 @default.
• W3204205013 hasConcept C2779134260 @default.
• W3204205013 hasConcept C2779159551 @default.
• W3204205013 hasConcept C2779422922 @default.
• W3204205013 hasConcept C2908647359 @default.
• W3204205013 hasConcept C3020479747 @default.
• W3204205013 hasConcept C44249647 @default.
• W3204205013 hasConcept C555293320 @default.
• W3204205013 hasConcept C71924100 @default.
• W3204205013 hasConcept C99454951 @default.
• W3204205013 hasConceptScore W3204205013C107130276 @default.
• W3204205013 hasConceptScore W3204205013C126322002 @default.
• W3204205013 hasConceptScore W3204205013C134018914 @default.
• W3204205013 hasConceptScore W3204205013C137627325 @default.
• W3204205013 hasConceptScore W3204205013C187212893 @default.
• W3204205013 hasConceptScore W3204205013C2778769438 @default.
• W3204205013 hasConceptScore W3204205013C2779134260 @default.
• W3204205013 hasConceptScore W3204205013C2779159551 @default.
• W3204205013 hasConceptScore W3204205013C2779422922 @default.
• W3204205013 hasConceptScore W3204205013C2908647359 @default.
• W3204205013 hasConceptScore W3204205013C3020479747 @default.
• W3204205013 hasConceptScore W3204205013C44249647 @default.
• W3204205013 hasConceptScore W3204205013C555293320 @default.
• W3204205013 hasConceptScore W3204205013C71924100 @default.
• W3204205013 hasConceptScore W3204205013C99454951 @default.
• W3204205013 hasFunder F4320310465 @default.
• W3204205013 hasIssue "1" @default.
• W3204205013 hasLocation W32042050131 @default.
• W3204205013 hasLocation W32042050132 @default.
• W3204205013 hasOpenAccess W3204205013 @default.
• W3204205013 hasPrimaryLocation W32042050131 @default.
• W3204205013 hasRelatedWork W2009394479 @default.
• W3204205013 hasRelatedWork W2049678232 @default.
• W3204205013 hasRelatedWork W2079043395 @default.
• W3204205013 hasRelatedWork W2120056260 @default.

• next